GTX Medical this week said it appointed Dave Marver as chief executive officer.
Marver has more than 15 years of experience in various leadership roles at Medtronic and has also held leadership positions at Cardiac Science Corporation and has co-founded two startup companies in orthopedics and sports technologies.
“GTX is the clear leader in developing technologies to transform the lives of people living with spinal cord injury,” Marver said in a news release. “It is a privilege to join the GTX team. I look forward to driving the advancement and eventual commercialization of these amazing technologies, starting with the U.S. clinical trial of our non-invasive therapy to improve movement in upper extremities later this year.”
GTX is currently developing non-invasive and implantable neuromodulation technologies for people with spinal cord injuries.
“It is an achievement for GTX to bring a CEO of Dave’s caliber on board to lead the strong team we have built to date. Dave is an accomplished chief executive whose diverse experiences will help propel GTX to its next phase of growth,” chairman of the board Jan Öhrström said.
